Qorvo (QRVO) Stock Forecast & Price Target

$70.49 -0.46 (-0.65%)

(As of 02:34 PM ET)

Qorvo - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 17 Analyst Ratings

Sell
2

Hold
13

Buy
2

Based on 17 Wall Street analysts who have issued ratings for Qorvo in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 2 have given a sell rating, 13 have given a hold rating, and 2 have given a buy rating for QRVO.

Consensus Price Target

$102.88
45.95% Upside

According to the 17 analysts' twelve-month price targets for Qorvo, the average price target is $102.88. The highest price target for QRVO is $135.00, while the lowest price target for QRVO is $73.00. The average price target represents a forecasted upside of 45.95% from the current price of $70.49.

Get the Latest News and Ratings for QRVO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Qorvo and its competitors.

QRVO Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	5 Buy rating(s)	8 Buy rating(s)
Hold	13 Hold rating(s)	13 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)
Sell	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)	2 Sell rating(s)
Consensus Price Target	$102.88	$102.88	$121.00	$109.11
Forecasted Upside	45.95% Upside	55.13% Upside	17.28% Upside	-2.13% Downside
Consensus Rating	Hold	Hold	Hold	Hold

This drone stock is setting up to transform medical supply delivery (Ad)

Drone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.

Click here to see how a new partnership could catapult this drone suppliers' growth

QRVO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

QRVO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Qorvo Stock vs. The Competition

Type	Qorvo	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.00	2.68	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	45.42% Upside	263.75% Upside	11.91% Upside
News Sentiment Rating	Positive News See Recent QRVO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/11/2024	Loop Capital 2 of 5 stars	G. Mobley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$73.00	+6.20%
10/30/2024	Barclays 3 of 5 stars		Lower Target	Equal Weight ➝ Equal Weight	$120.00 ➝ $90.00	+22.97%
10/30/2024	JPMorgan Chase & Co. 3 of 5 stars		Lower Target	Underweight ➝ Underweight	$115.00 ➝ $95.00	+29.18%
10/30/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $90.00	+19.89%
10/30/2024	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $90.00	+19.84%
10/30/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Underperform ➝ Underperform	$115.00 ➝ $80.00	-20.38%
Get the Latest News and Ratings for QRVO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Qorvo and its competitors with MarketBeat's FREE daily newsletter.
10/30/2024	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$142.00 ➝ $105.00	+4.50%
10/30/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Sankar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$125.00 ➝ $85.00	-15.41%
10/30/2024	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Acree Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Hold
10/30/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Pajjuri Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
10/30/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Ackerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$80.00	-20.38%
10/28/2024	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy ➝ Buy	$135.00 ➝ $135.00	+35.68%
10/25/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$120.00 ➝ $100.00	-0.43%
10/11/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight	$130.00 ➝ $120.00	+18.23%
7/31/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$105.00 ➝ $118.00	+4.42%
7/31/2024	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$105.00 ➝ $120.00	+6.27%
5/2/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$115.00 ➝ $105.00	-6.16%
11/3/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Market Perform ➝ Market Perform	$110.00 ➝ $100.00	+16.99%
11/2/2023	Summit Insights Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/10/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Sell	$116.00 ➝ $78.00	-17.81%
8/3/2023	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$100.00 ➝ $110.00	+3.67%
7/19/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$125.00	+18.10%
5/9/2023	KGI Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Outperform
4/5/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$110.00	+15.79%
2/2/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform	$80.00 ➝ $100.00	-11.92%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:54 PM ET.

QRVO Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Qorvo is $102.88, with a high forecast of $135.00 and a low forecast of $73.00.
: 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Qorvo in the last twelve months. There are currently 2 sell ratings, 13 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" QRVO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QRVO, but not buy additional shares or sell existing shares.
: According to analysts, Qorvo's stock has a predicted upside of 45.95% based on their 12-month stock forecasts.
: Over the previous 90 days, Qorvo's stock had 4 downgrades by analysts.
: Qorvo has been rated by research analysts at Bank of America, Barclays, Benchmark, BNP Paribas, Craig Hallum, JPMorgan Chase & Co., Loop Capital, Morgan Stanley, Needham & Company LLC, Piper Sandler, Raymond James, Susquehanna, TD Cowen, and UBS Group in the past 90 days.
: Analysts like Qorvo less than other "computer and technology" companies. The consensus rating for Qorvo is Hold while the average consensus rating for "computer and technology" companies is Moderate Buy. Learn more on how QRVO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Healthcare Takes A Big Step Forward With The Help of A.I. (Ad)

To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems. For its next act, AI is going to help save lives. Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare.

Click here to learn more about the booming eHealth industry - and see which microcap will be at the

This page (NASDAQ:QRVO) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Qorvo (QRVO) Stock Forecast & Price Target